Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall sentiment reflects strong agreement and high interest, with posts emphasizing the substantial RSV burden in Kenyan children and the importance of developing maternal vaccines and monoclonal antibodies. The tone suggests a recognition of the study's potential to inform health strategies, using phrases like 'substantial disease burden' and 'could help reduce this burden,' indicating a thoughtful engagement with the research's implications.
Most discussions recognize the significance of the study’s findings, emphasizing the high burden of RSV and the potential benefits of vaccines and monoclonal antibodies.
Posts demonstrate strong interest by highlighting implications for public health interventions and the importance of the data, indicating engagement with the subject matter.
Several posts delve into the potential for vaccine development and policy impacts, showing a moderate depth of discussion beyond simple acknowledgment.
Discussions reflect an understanding of the study’s importance, referencing global health strategies and the need for intervention, suggesting notable influence on health policy considerations.
New: @Otee2 et al find a substantial disease burden in Kenya due to #RSV infection. Development & use of maternal #vaccines and affordable long-lasting monoclonal antibodies could help reduce this burden: https://t.co/bpGqw1mt8r @PATHtweets @KEMRI_Wellcome @CDCKenya @markjit
RT @BMCMedicine: New: @Otee2 et al find a substantial disease burden in Kenya due to #RSV infection. Development & use of maternal #vaccine…
New from #wellcometrust https://t.co/DXrLxsL8Mx Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018.
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018 https://t.co/m7Y5yIuXff
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018 https://t.co/LmNJ5Ol3SQ
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under ... https://t.co/vVLVKdjZSs Respiratory syncytial virus (RSV) is among the leading childhood causes of viral pneumonia worldwide. Establishing RSV-associated morbidity and ...
RSV is a major cause of viral pneumonia in children. Data from Kenya (2010-2018) highlights its significant impact on outpatient visits, hospitalizations, and mortality, especially in infants under 6 months, emphasizing…
New from #wellcometrust https://t.co/DXrLxsL8Mx Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018.
RT @BMCMedicine: New: @Otee2 et al find a substantial disease burden in Kenya due to #RSV infection. Development & use of maternal #vaccine…
New: @Otee2 et al find a substantial disease burden in Kenya due to #RSV infection. Development & use of maternal #vaccines and affordable long-lasting monoclonal antibodies could help reduce this burden: https://t.co/bpGqw1mt8r @PATHtweets @KEMRI_Wellcome @CDCKenya @markjit
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under ... https://t.co/vVLVKdjZSs Respiratory syncytial virus (RSV) is among the leading childhood causes of viral pneumonia worldwide. Establishing RSV-associated morbidity and ...
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018 https://t.co/m7Y5yIuXff
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018 https://t.co/LmNJ5Ol3SQ